NCT05733715 2025-03-03Neoadjuvant Pembrolizumab and Lenvatinib for Renal Cell CarcinomaAbramson Cancer Center at Penn MedicinePhase EARLY_PHASE1 Recruiting30 enrolled
NCT06204614 2024-01-12Drug Screening Using IMD in Bladder CancerBrigham and Women's HospitalPhase EARLY_PHASE1 Unknown18 enrolled